These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9434905)

  • 1. T-cell receptor structure and TCR complexes.
    Wilson IA; Garcia KC
    Curr Opin Struct Biol; 1997 Dec; 7(6):839-48. PubMed ID: 9434905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes.
    Arcus VL; Proft T; Sigrell JA; Baker HM; Fraser JD; Baker EN
    J Mol Biol; 2000 May; 299(1):157-68. PubMed ID: 10860729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A flexible docking approach for prediction of T cell receptor-peptide-MHC complexes.
    Pierce BG; Weng Z
    Protein Sci; 2013 Jan; 22(1):35-46. PubMed ID: 23109003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules.
    Hâkansson M; Petersson K; Nilsson H; Forsberg G; Björk P; Antonsson P; Svensson LA
    J Mol Biol; 2000 Sep; 302(3):527-37. PubMed ID: 10986116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycoplasma superantigen is a CDR3-dependent ligand for the T cell antigen receptor.
    Hodtsev AS; Choi Y; Spanopoulou E; Posnett DN
    J Exp Med; 1998 Feb; 187(3):319-27. PubMed ID: 9449712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the streptococcal superantigen SPE-C: dimerization and zinc binding suggest a novel mode of interaction with MHC class II molecules.
    Roussel A; Anderson BF; Baker HM; Fraser JD; Baker EN
    Nat Struct Biol; 1997 Aug; 4(8):635-43. PubMed ID: 9253413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A window of opportunity for cooperativity in the T Cell Receptor.
    Martin-Blanco N; Blanco R; Alda-Catalinas C; Bovolenta ER; Oeste CL; Palmer E; Schamel WW; Lythe G; Molina-París C; Castro M; Alarcon B
    Nat Commun; 2018 Jul; 9(1):2618. PubMed ID: 29976994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC.
    Sethi DK; Schubert DA; Anders AK; Heroux A; Bonsor DA; Thomas CP; Sundberg EJ; Pyrdol J; Wucherpfennig KW
    J Exp Med; 2011 Jan; 208(1):91-102. PubMed ID: 21199956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition.
    Borg NA; Ely LK; Beddoe T; Macdonald WA; Reid HH; Clements CS; Purcell AW; Kjer-Nielsen L; Miles JJ; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Feb; 6(2):171-80. PubMed ID: 15640805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
    Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
    Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting interactions between T cell receptors and MHC-peptide complexes.
    Roomp K; Domingues FS
    Mol Immunol; 2011 Jan; 48(4):553-62. PubMed ID: 21106246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crystal structure of a T cell receptor in complex with peptide and MHC class II.
    Reinherz EL; Tan K; Tang L; Kern P; Liu J; Xiong Y; Hussey RE; Smolyar A; Hare B; Zhang R; Joachimiak A; Chang HC; Wagner G; Wang J
    Science; 1999 Dec; 286(5446):1913-21. PubMed ID: 10583947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPID-T: database for sequence-structure-function information on T-cell receptor/peptide/MHC interactions.
    Tong JC; Kong L; Tan TW; Ranganathan S
    Appl Bioinformatics; 2006; 5(2):111-4. PubMed ID: 16722775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-step binding mechanism for T-cell receptor recognition of peptide MHC.
    Wu LC; Tuot DS; Lyons DS; Garcia KC; Davis MM
    Nature; 2002 Aug; 418(6897):552-6. PubMed ID: 12152083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen.
    Fields BA; Malchiodi EL; Li H; Ysern X; Stauffacher CV; Schlievert PM; Karjalainen K; Mariuzza RA
    Nature; 1996 Nov; 384(6605):188-92. PubMed ID: 8906797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information-Driven Docking for TCR-pMHC Complex Prediction.
    Peacock T; Chain B
    Front Immunol; 2021; 12():686127. PubMed ID: 34177934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superantigens: structure and relevance to human disease.
    Johnson HM; Torres BA; Soos JM
    Proc Soc Exp Biol Med; 1996 Jun; 212(2):99-109. PubMed ID: 8650257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity T cell receptors from yeast display libraries block T cell activation by superantigens.
    Kieke MC; Sundberg E; Shusta EV; Mariuzza RA; Wittrup KD; Kranz DM
    J Mol Biol; 2001 Apr; 307(5):1305-15. PubMed ID: 11292343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope flexibility and dynamic footprint revealed by molecular dynamics of a pMHC-TCR complex.
    Reboul CF; Meyer GR; Porebski BT; Borg NA; Buckle AM
    PLoS Comput Biol; 2012; 8(3):e1002404. PubMed ID: 22412359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural alterations in peptide-MHC recognition by self-reactive T cell receptors.
    Wucherpfennig KW; Call MJ; Deng L; Mariuzza R
    Curr Opin Immunol; 2009 Dec; 21(6):590-5. PubMed ID: 19699075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.